Advertise on podcast: Gavel & Pestle Podcast

In this episode of Gavel and Pestle, Todd sits down with Lucas W. Morgan, Esq. to discuss the ins and outs of navigating the board of pharmacy. As a lawyer with extensive experience in the field, Lucas shares his insights and tips for pharmacists and pharmacy professionals who may need to interact with the board of pharmacy. From licensing issues to disciplinary actions, Todd and Lucas cover a wide range of topics to help listeners stay informed and prepared. Tune in to learn from their valuable discussion on "Navigating Board of Pharmacy".

Title: Darshan Kulkarni on Amazon Pharmacy In 2017, Darshan Kulkarni PharmD, MS, Esq., predicted that Amazon would soon disrupt the pharmaceutical industry on the Gavel & Pestle Podcast. Three years later, his eerily accurate predictions are unfolding before us. On this special episode of Gavel & Pestle, the FDA regulatory lawyer, author, professor, and speaker returns to pass the baton to the podcast’s new host Brooke Kulusich. They discuss Amazon Pharmacy’s potential to singlehandedly reshape the pharmaceutical supply chain, its implications for patient health data and drug prices, and the future of pharmacy from drone delivery to Alexa pharmacists.  Listen to Darshan’s predictions here.  Follow Gavel & Pestle on Twitter here.  Contact us today for a Gavel & Pestle Podcast appearance at publisher@pharmacypodcast.com. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

“If you think compliance is expensive, try non-compliance.”  -Former U.S. Deputy Attorney, General Paul McNulty On this episode of Gavel and Pestle, Natalia Mazina, Esq., regulatory counsel at Mazina Law and founder of RxPolicy, joins host Brooke Kulusich to share her expertise in pharmacy compliance, third-party payer audits, and pharmacy benefit manager (PBM) disputes. They discuss the most common compliance mistakes that pharmacies make, the REAL implications of the Rutledge v. PCMA decision, and how independent pharmacies can think outside-the-box in their approach to PBMs. Follow Gavel & Pestle on Twitter here.  Contact us today for a Gavel & Pestle Podcast appearance at publisher@pharmacypodcast.com. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

We welcome our newest host, pharmacy student at the University of Pittsburgh School of Pharmacy ‘22 Ms. Brooke E. Kulusich Brooke mentions: "Throughout pharmacy school, my passion for patient care has remained the driving force in my career. I have gained a deep appreciation for the vital role of pharmacists in the community and have been inspired to scale my impact beyond the individual patient level. As one of the most highly-regulated industries, pharmacy presents a unique opportunity to engage clinicians in shaping policies that carry our profession forward. Through Gavel & Pestle, I hope to share my passion for the intersection of healthcare and the law and look forward to learning alongside our audience through conversations with experts. As a third-year student pharmacist, I am interested in a career in pharmacy law or association management that would enable me to leverage my patient care experiences to advance policy decisions and improve patient access to care. Upon graduation, I hope to pursue a clinical or commercial role in a healthcare, government, private sector or public sector leadership position."  Contact us today for a Gavel & Pestle Podcast episode appearance.  Today's episode is sponsored by CEimpact:   https://www.ceimpact.com/marketplace  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of the Gavel & Pestle Podcast, Darshan talks about the last mile of drug delivery and the challenges faced by patients getting their medications on time. In the last mile, the efficacy of a medicine must still be maintained, but managing and controlling the delivery can be an issue. The cost of technology to monitor may not be justified given that the value of the medicines being shipped to the final destination might be much lower than the value that was initially bulk shipped from the manufacturer. In this article we will explore the challenges of deploying technology and the circumstances under which tech can be used to cost-effectively manage and control the last mile delivery of medicines.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Purdue College of Pharmacy is proud to present BoilerWoRx: a multidisciplinary response to public health needs in Indiana, initially focusing on the opioid epidemic. BoilerWoRx is a strategic mobilehealth initiative that will bring vital services to communities across Indiana. The BoilerWoRx program, in partnership with the Tippecanoe County Health Department and the Lafayette Transitional Housing Center, will be hosted their first event on Saturday, April 21, 2018 at Lafayette Transitional Housing at the Howarth Center in Lafayette, Indiana.  The BoilerWoRx team will provide counseling, education, training, drug disposal and Hepatitis A immunizations. This event is open to everyone so come out and learn more about BoilerWoRx. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Darshan and Major talk about 23 & Me Data collected and it's potential ramifications to our privacy.  "Embedded in our genetic code is all kinds of sensitive data that could be compromising in the wrong hands without genetic privacy protections, the information stored in our genes might be used to discriminate against us or send us targeted ads. For these reasons, some have said we should skip out on consumer DNA tests if we value our privacy. Last week, after the FDA gave DNA testing company 23andMe the greenlight to offer consumers disease risk assessments, there was a new wave of warnings. “The product isn’t really a kit...the product is you,” Popular Science wrote after the announcement. Others have speculated that the company’s long-term goals include selling your data for advertising purposes. Let’s be clear here. 23andMe definitely is selling your data to third party companies, research institutions and nonprofits. But it is not selling your genetic data to those entities in order for them to sell you things. It is selling de-identified, aggregate data for research, if you give them consent." From original article, by Kristen V. Brown:  https://gizmodo.com/23andme-is-selling-your-data-but-not-how-you-think-1794340474  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Darshan talks about the Telemedicine effect on modern healthcare. The term telehealth includes a broad range of technologies and services to provide patient care and improve the healthcare delivery system as a whole. Telehealth is different from telemedicine because it refers to a broader scope of remote healthcare services than telemedicine. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Major & Darshan with the Gavel & Pestle Podcast talk about 'Patient Centricity' and being aware of the patient's experience and their pharmacy healthcare provider.  Contact Darshan:  https://www.linkedin.com/in/darshankulkarni/  @DarshanTalks  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Gavel & Pestle Podcast host Darshan KulKarni talks with Emmanuel Fombu, MD, MBA (Manny) the author of the best selling book titled, The Future of Healthcare: Humans and Machines Partnering for Better Outcomes Emmanuel Fombu, MD, MBA, is a physician, author, speaker and healthcare executive turned Silicon Valley entrepreneur. As a medical futurist and 2017 winner of the prestigious New York City Health Business Leaders Boldest Digital Health Influencer Award, Dr. Fombu champions the potential for the internet of things, artificial intelligence and machine learning to revolutionize the healthcare industry. https://www.emmanuelfombu.com/  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Telepharmacy is the delivery of pharmaceutical care via telecommunications to patients in locations where they may not have direct contact with a pharmacist. It is an instance of the wider phenomenon of telemedicine, as implemented in the field of pharmacy. Darshan Kulkarni, host of the Gavel & Pestle Podcast and VP Regulatory Strategy & Policy with Synchrogenix interviews Timothy Youkhana President with Scaled Enterprise Solutions about telepharmacy opportunities for pharmacy business.  Telepharmacy services include drug therapy monitoring, patient counseling, prior authorization and refill authorization for prescription drugs, and monitoring of formulary compliance with the aid of teleconferencing or videoconferencing. Remote dispensing of medications by automated packaging and labeling systems can also be thought of as an instance of telepharmacy. Telepharmacy services can be delivered at retail pharmacy sites or through hospitals, nursing homes, or other medical care facilities. The term can also refer to the use of videoconferencing in pharmacy for other purposes, such as providing education, training, and management services to pharmacists and pharmacy staff remotely. ABOUT --Scaled Enterprise Solutions https://ses.healthcare/about/  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Darshan & Major with the Gavel & Pestle Podcast returns to talk about the Amazonification of Healthcare.  Dr. Kulkarni is the Principal Attorney at the Kulkarni Law Firm. He provides regulatory and legal advice to pharmacies and other FDA regulated entities and their service providers. He speaks and regularly advises on current legal and compliance related matters including the physician payment sunshine act, clinicaltrials.gov, the False Claims Act, the Anti-Kickback Law and other developments of laws and regulations that affect the life sciences industry and compounding facilities. Contact: darshan@conformlaw.com #Amazonification  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices